Find your tools for building human cell-based models & screening assays
NEW Human iPSC-Derived Astrocytes (ax0665) available now
Axol uses human iPSCs to generate specific cell types We do NOT use animal cells or embryonic stem cells (ESCs)
Featured Product
Microglia
Human iPSC-derived Microglia provide a reliable and consistent model that phenotypically recapitulates human microglia responses in vitro.
Featured Service
Cell Reprogramming
A complete suite of custom cell reprogramming and characterization services from dedicated specialists to generate iPSCs from human cells using cutting edge technologies.
Featured White Paper
Atrial Cardiomyocytes
Are you using non-human cell models for your cardiac research? Download our new white paper to find out why human iPSC-derived Atrial Cardiomyocytes could improve your data.
Welcome to Axol Bioscience
YOUR HUMAN CELL CULTURE SPECIALISTS
We provide highly validated human iPSC-derived cells and primary cells from healthy donors and patients of specific disease backgrounds, together with optimized media and growth supplements. Axol aims to develop the best human cell biology research tools to advance medical research and drug discovery. Combining our passion for science with quality, innovation and customer service, we deliver robust and reliable products that our customers need to advance their research faster.
Chief Operating Officer appointed at Axol Bioscience
15 May 2019
We are delighted to announce that Chris Kirton joins us as our Chief Operating Officer; a senior operations leader with over 15 years of drug development, commercial and operational management experience in both industry and academia. Chris joins us from a leading supplier in the biotech industry and takes up his leadership role at Axol, bringing with him his extensive operational experience at the highest levels, focusing Axol's position and supporting growth within the Human iPSC-Derived Stem Cell market.
Major success for MESO-BRAIN partners will lead to breakthrough technology for developing new brain models
Axol Bioscience launch human iPSC-derived Microglia
13 December 2018
Cambridge, UK – (6th December 2018) – Axol Bioscience, the human cell culture specialist, is launching a new line of Human induced Pluripotent Stem Cells (iPSC)-derived Microglia for the consistent and reproducible study of neuroglia and their involvement in neurodegenerative diseases, including Alzheimer’s disease, multiple sclerosis and Parkinson’s disease.
Good Cell Culture Practice in Toxicology Seminar
16 October 2018
Axol Bioscience is presenting at the two-day seminar hold by Evercyte and Altetox in Vienna, from 30-31 October. Book your ticket today.
How to Order
To place an order or request a quotation simply add the desired products to your shopping cart and then click "Process Checkout" to provide the billing and shipping information. On the payment page you can then either pay immediately or download a quotation.
Order Confirmed
Thank you for your order. We have received your purchase order successfully and will start processing it as soon as possible.
We will be in touch shortly.
Issue with Order Detected
There was an issue with your submitted order as follows: Unidentified Error Please resolve this issue and try again. If you are unable to do so, please contact us via the contact form and we'll do our best to resolve your issue.
